The Classic Myeloproliferative Neoplasms
Optimizing Laboratory Testing for Hematologic Disorders Series
Click CC to turn on closed captioning.
Dr. Hanson is presenting the second in our series “Optimizing Laboratory Testing for Hematologic Disorders.” This series will address guidelines for appropriate laboratory test utilization in hematologic disorders and represents the combined effort of the Divisions of Hematopathology and Laboratory Genetics. This presentation will discuss the appropriate utilization of the JAK2 and MPL gene tests for evaluating possible myeloproliferative neoplasms.
- Curtis A. Hanson, MD of the Division of Hematopathology at Mayo Clinic in Rochester, Minnesota
- Hematopathology Consultation
- Chromosome Analysis, Hematologic Disorders, Bone Marrow
- BCR/ABL, mRNA Detection, Reverse Transcription PCR (RT_PCR) Qualitative, Diagnostic Assay
- BCR/ABL, Translocation 9;22, FISH (D-FISH)
- Erythropoietin (EPO), Serum
- JAK2 V617F Mutation Detection, Blood
- JAK2 V617F Mutation Detection, Bone Marrow
- JAK2 V617F Mutation Detection, Varies
Hematologic Disorders Series
- Hot Topic: Leukocyte Alkaline Phosphatase Stain (LAP) - Optimizing Laboratory Testing for Hematologic Disorders Series
- Hot Topic: Classic Myeloproliferative Neoplasms
- Hot Topic: Bone Marrow Genetic Studies for Malignant Lymphoma Staging
Forward to a Colleague
Share this presentation with:
- General Practitioners
If you have questions, e-mail .